Indiana Blood and Marrow Transplant

Indianapolis, Indiana 46237

0 studies enrolling now · 4 studies all time

What they study most

Acute Graft-versus-host Disease, Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia (CLL), Chronic Myelogenous Leukemia, Chronic Myelogenous Leukemia (CML), For Donors, For Recipients, Graft-versus-host Disease (GVHD), Hematologic Malignancies

Studies at this site

• GRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host Disease — Completed
• A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML) — Completed
• Study of ProTmune for Allogeneic HCT in Adult Patients With Hematologic Malignancies — Completed
• A Safety and Tolerability Study of CDX-301 With or Without Plerixafor for Stem Cell Mobilization in Matched Related Allogeneic Donor/Recipient Sibling Transplant Pairs — Stopped early